Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Exo-galactanase/
beta-galactosidase
(
EC 3.2.1.23
) activity is thought to be responsible for the loss of galactosyl residues from the cell walls of ripening tomatoes. Transgenic tomato plants (Lycopersicon esculentum Mill cv. Ailsa Craig) with reduced exo-galactanase/
beta-galactosidase
mRNA were generated to test this hypothesis and to investigate the role of the enzyme in fruit softening. A previously identified tomato
beta-galactosidase
cDNA clone,
TBG1
, was used in the experiments. Heterologous expression of the clone in yeast demonstrated that
TBG1
could release galactosyl residues from tomato cell wall galactans. Transgenic plants showed a reduction in
TBG1
mRNA to 10% of normal levels in the ripening fruits. However, despite the reduction in message, total
beta-galactosidase
and exo-galactanase activities were unaffected. Furthermore, there was no apparent effect on levels of cell wall galactosyl residues when compared with the control. It was concluded that during the ripening of tomato fruits a family of beta-galactosidases capable of degrading cell wall galactans are active and down-regulation of
TBG1
message to 10% was insufficient to alter the degree of galactan degradation.
...
PMID:Down-regulation of a ripening-related beta-galactosidase gene (TBG1) in transgenic tomato fruits. 1141 2